Literature DB >> 19058313

Hepatoma cells up-regulate expression of programmed cell death-1 on T cells.

Ji Chen1, Xue-Jie Wu, Gui-Qiang Wang.   

Abstract

AIM: To investigate the effect of hepatoma cells on up-regulation of programmed cell death-1 (PD-1), and the function of PD-1 on T cells.
METHODS: HepG2 or HepG2.2.1.5 cells were co-cultured with a lymphoma cell line-Jurkat cells. PD-1 expression was detected by flow cytometry. IL-2, INF-gamma and IL-10 in culture supernatant were detected by enzyme-linked immunosorbent assay (ELISA). Cytotoxic action of T cells was determined by MTT reduction assay-direct mononuclear cell cytotoxicity assay.
RESULTS: The PD-1 expression on Jurkat cells increased by 16.17% +/- 2.5% and 17.43% +/- 2.2% after HepG2 or HepG2.2.1.5 cells were co-cultured for 48 h. The levels of IL-2, INF-gamma and IL-10 in the culture supernatant were 202.9 +/- 53.0 pg/mL, 88.6 +/- 4.6 pg/mL and 63.7 +/- 13.4 pg/mL respectively, which were significantly higher than those (102.9 +/- 53 pg/mL, 39.3 +/- 4.2 pg/mL, and 34.6 +/-13.7 pg/mL) in the control group (P < 0.05). The OD value for MTT assay in the blocking group (0.29 +/- 0.06) was significantly higher than that (0.19 +/- 0.09) in the control group (P < 0.05).
CONCLUSION: PD-1 expression on Jurkat cells is up-regulated by hepatoma cells, cytokines and cytotoxic action are elevated after PD-1/PD-L1 is blocked.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19058313      PMCID: PMC2773882          DOI: 10.3748/wjg.14.6853

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.

Authors:  H Dong; G Zhu; K Tamada; L Chen
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.

Authors:  Masayoshi Ishida; Yoshiko Iwai; Yoshimasa Tanaka; Taku Okazaki; Gordon J Freeman; Nagahiro Minato; Tasuku Honjo
Journal:  Immunol Lett       Date:  2002-10-21       Impact factor: 3.685

3.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Authors:  Y Latchman; C R Wood; T Chernova; D Chaudhary; M Borde; I Chernova; Y Iwai; A J Long; J A Brown; R Nunes; E A Greenfield; K Bourque; V A Boussiotis; L L Carter; B M Carreno; N Malenkovich; H Nishimura; T Okazaki; T Honjo; A H Sharpe; G J Freeman
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

4.  B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B.

Authors:  Liangen Chen; Zheng Zhang; Weiwei Chen; Zhidong Zhang; Yonggang Li; Ming Shi; Jiyuan Zhang; Lieping Chen; Shengdian Wang; Fu-Sheng Wang
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

5.  Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Authors:  Haidong Dong; Scott E Strome; Diva R Salomao; Hideto Tamura; Fumiya Hirano; Dallas B Flies; Patrick C Roche; Jun Lu; Gefeng Zhu; Koji Tamada; Vanda A Lennon; Esteban Celis; Lieping Chen
Journal:  Nat Med       Date:  2002-06-24       Impact factor: 53.440

Review 6.  The genetic basis of systemic lupus erythematosus--knowledge of today and thoughts for tomorrow.

Authors:  Ludmila Prokunina; Marta Alarcon-Riquelme
Journal:  Hum Mol Genet       Date:  2004-02-05       Impact factor: 6.150

7.  Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer.

Authors:  Martin Loos; Nathalia A Giese; Jörg Kleeff; Thomas Giese; Matthias M Gaida; Frank Bergmann; Melanie Laschinger; Markus W Büchler; Helmut Friess
Journal:  Cancer Lett       Date:  2008-05-16       Impact factor: 8.679

8.  PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.

Authors:  Guoping Peng; Shuping Li; Wei Wu; Xufei Tan; Yiqiong Chen; Zhi Chen
Journal:  Mol Immunol       Date:  2007-09-14       Impact factor: 4.407

9.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

10.  Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content.

Authors:  T Cotner; J M Williams; L Christenson; H M Shapiro; T B Strom; J Strominger
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  5 in total

1.  Programmed cell death protein 1 and programmed death-ligand 1 are expressed on the surface of some small-cell lung cancer lines.

Authors:  Hiromichi Yamane; Hideko Isozaki; Masami Takeyama; Nobuaki Ochi; Kenichiro Kudo; Yoshihiro Honda; Tomoko Yamagishi; Toshio Kubo; Katsuyuki Kiura; Nagio Takigawa
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

2.  Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma.

Authors:  Zhen Zeng; Feng Shi; Lin Zhou; Min-Na Zhang; Yan Chen; Xiu-Juan Chang; Yin-Ying Lu; Wen-Lin Bai; Jian-Hui Qu; Chun-Ping Wang; Hong Wang; Min Lou; Fu-Sheng Wang; Ji-Yun Lv; Yong-Ping Yang
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

Review 3.  T-cell exhaustion in the tumor microenvironment.

Authors:  Y Jiang; Y Li; B Zhu
Journal:  Cell Death Dis       Date:  2015-06-18       Impact factor: 8.469

4.  The Immunostimulative Effect and Mechanisms of a Novel Mouse Anti-Human PD-1 Monoclonal Antibody on Jurkat Lymphocytic Cells Cocultured with Hepatoma Cells.

Authors:  Ziwei Li; Bin Li; Li Li; Guanying Wang; Yuanyuan Li; Ruoqiu Fu; Yue Ming; Rui Ni; Jiming Wang; George Ye; Jianhong Chen
Journal:  Onco Targets Ther       Date:  2020-11-27       Impact factor: 4.147

5.  Dynamic chromatin regulatory landscape of human CAR T cell exhaustion.

Authors:  David G Gennert; Rachel C Lynn; Jeff M Granja; Evan W Weber; Maxwell R Mumbach; Yang Zhao; Zhana Duren; Elena Sotillo; William J Greenleaf; Wing H Wong; Ansuman T Satpathy; Crystal L Mackall; Howard Y Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.